Pacific Biosciences Of California (PACB) Gross Profit Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.15% |
| 10 | Pacific Biosciences Of California | 415.91 Mn | 139.95 Mn | 12.84 Mn | 9.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57% |
| Dec 31, 2025 | 47.71% |
| Sep 30, 2025 | 5.49% |
| Jun 30, 2025 | -3.21% |
| Mar 31, 2025 | -27.99% |
| Dec 31, 2024 | -15.66% |
| Jun 30, 2024 | -24.42% |
| Mar 31, 2024 | -4.56% |
| Dec 31, 2023 | -5.67% |
| Sep 30, 2023 | 36.34% |
| Jun 30, 2023 | 32.97% |
| Mar 31, 2023 | 9.24% |
| Dec 31, 2022 | -26.48% |
| Sep 30, 2022 | 25.13% |
| Jun 30, 2022 | 18.98% |
| Mar 31, 2022 | 40.38% |
| Dec 31, 2021 | 42.90% |
| Jun 30, 2021 | 15.78% |
| Mar 31, 2021 | 21.16% |
| Dec 31, 2020 | 6.29% |